LOW MORBIDITY AND NO MORTALITY OF HIGH-DOSE CYCLOPHOSPHAMIDE, THIOTEPA AND MITOXANTRONE PLUS AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL SUPPORT FOR HIGH-RISK BREAST-CANCER PATIENTS
N. Kroger et al., LOW MORBIDITY AND NO MORTALITY OF HIGH-DOSE CYCLOPHOSPHAMIDE, THIOTEPA AND MITOXANTRONE PLUS AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL SUPPORT FOR HIGH-RISK BREAST-CANCER PATIENTS, European journal of cancer, 34, 1998, pp. 92-92